About
⚠️ Placeholder to complete : Philippe needs to write his own prose for this institutional page. This content is a draft that can serve as a starting point — to be edited entirely via Sveltia CMS.
Our mission
Dotation.org redistributes your donations to innovative early-stage projects — medical, environmental, scientific — that haven’t yet found their place with traditional funders.
Our approach is that of the high-performance non-profit: we apply the rigor an investor uses for portfolio holdings to philanthropic projects — demanding selection, operational follow-up, impact transparency.
Why early-stage
[TO COMPLETE BY PHILIPPE — elements to include:]
- The gap between fundamental research (state-funded) and venture capital (mature startups)
- “Deeptech” early-stage projects that are too early for the market and too applied for grants
- The amplified impact of well-timed support
Our model
[TO COMPLETE BY PHILIPPE — elements to include:]
- How we select projects (criteria, process)
- How we measure impact (annual report, transparency)
- How donations are allocated (% to the project vs. operational overhead)
The team
[TO COMPLETE BY PHILIPPE — typically:]
- Philippe Nussbaumer — Founder, Écloseur SAS
- [Other team members or collaborators]
Our story
Dotation.org is operated by Écloseur SAS, a French company whose mission is to identify and support innovations with strong impact potential at the early stage.
[TO COMPLETE BY PHILIPPE: why Dotation.org was created, when, what initial observation]
Contact us
A question, a project to suggest, a partnership? contact@dotation.org
See also: Contact page